Follow
Liquid Biopsy
A liquid biopsy is a diagnostic test using liquid biological samples. Considered non-invasive, it can be used to track cancers, heart issues, and do prenatal diagnosis.
What's Popular in Liquid Biopsy
-
DEC 03, 2024Immunology
Join us to explore the latest insights into the future of precision oncology! This year, the Agilent Precision Oncology ...NOV 04, 2024Cancer
Early cancer detection gives patients the best odds of successful treatment. Typically, cancers diagnosed at an ea ...Written By: Katie KokolusMAY 01, 2024Cancer
Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sampl ...Sponsored By: Omega Bio-tekJAN 04, 2024Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca ...Written By: Carmen LeitchJAN 02, 2024Cancer
Immunotherapies have drastically improved the array of treatment options available for cancer patients. In contras ...Written By: Katie Kokolus
DEC 03, 2024
Immunology
Join us to explore the latest insights into the future of precision oncology! This year, the Agilent Precision Oncology
...
NOV 04, 2024
Cancer
Early cancer detection gives patients the best odds of successful treatment. Typically, cancers diagnosed at an ea
...
Written By:
Katie Kokolus
MAY 01, 2024
Cancer
Recent advancements in liquid biopsies have demonstrated the potential of cfDNA as a universal, minimally invasive sampl
...
Sponsored By:
Omega Bio-tek
JAN 04, 2024
Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca
...
Written By:
Carmen Leitch
JAN 02, 2024
Cancer
Immunotherapies have drastically improved the array of treatment options available for cancer patients. In contras
...
Written By:
Katie Kokolus
SEP 11, 2023
Cell & Molecular Biology
Labroots is thrilled to announce that registration is open for the 7th Annual Event in the Cell Biology Virtual Event Se
...
Written By:
Laurence Tognetti, MSc
SEP 04, 2023
Cancer
Metastasis is one of the main obstacles in treating cancer. Studying circulating tumor cells (CTCs) and CTC clusters at
...
MAY 09, 2023
Genetics & Genomics
Labroots is proud to announce that registration is open for the 11th Annual Event in the Genetics Virtual Event Series,
...
Written By:
Laurence Tognetti, MSc
JAN 17, 2023
Clinical & Molecular DX
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years
...
Sponsored By:
Roche Sequencing and Life Science
-
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...NOV 19, 2025 | 9:00 AMC.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....Speaker: Dr. Laura Keller, PharmD, PhD , Dr. Nadim Fares, MD, PhD
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
AUG 27, 2025 | 10:00 AM
C.E. CREDITS
Discover how global leaders are advancing equitable access to liquid biopsy with MSK-ACCESS® & SOPHiA DDM™ in this expert-led webinar....
Speaker:
Florian Klemm, M.D., Ph.D
, Ryan Demers, MSc
, Persephone du Parcq
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
NOV 19, 2025 | 9:00 AM
C.E. CREDITS
Discover how MSK-ACCESS® powered with SOPHiA DDM™ enhances liquid biopsy accuracy by filtering CH variants to guide precise cancer treatment decisions....
Speaker:
Dr. Laura Keller, PharmD, PhD
, Dr. Nadim Fares, MD, PhD
OCT 21, 2025 | 7:00 AM
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulatin...
SEP 10, 2025 | 11:00 AM
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minima...
AUG 27, 2025 | 10:00 AM
C.E. CREDITS
Discover how global leaders are advancing equitable access to liquid biopsy with MSK-ACCESS® & SOPHiA DDM™ in this expert-led webinar....
Speaker:
Florian Klemm, M.D., Ph.D
, Ryan Demers, MSc
, Persephone du Parcq
July 31, 2025 7am PST/10am EST/4pm CET
microRNAs are emerging as powerful biomarkers for precision medicine, offering valuable insights into disease mechanisms, diagnosis, prognosis, and treatment response. However, successful di...
JUN 25, 2025 | 11:00 PM
Learn how blood-based multiomics reveals tumor-specific biomarkers in pediatric cancers, aiding personalized immunotherapy-without invasive biopsies....
MAY 20, 2025 | 10:00 AM
In this webinar, we expand on how the innovations of NovaSeq X are making multiomics a reality. We will highlight data from multi-project runs, massive single cell and CRISPR applications, a...
On Demand
LGC offers a comprehensive portfolio of reference standards and scientific tools for a wide range of disciplines. The focus of this talk will be on reference materials for clinical NGS produ...
Speaker:
Andrew T. Anfora, BS, PhD
-
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2026 held on April 29th, 2026! The Precision Medicine:...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...NOVEMBER 19, 2025 | 9:00 AM ETC.E. CREDITS
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series wil...OCT 01, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...SEP 10, 2025 | 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2026 held on April 29th, 2026! The Precision Medicine:...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
NOVEMBER 19, 2025 | 9:00 AM ET
C.E. CREDITS
The Precision Oncology Showcase is a webinar series sponsored by SOPHiA GENETICS, set to redefine how precision oncology is practiced worldwide. Taking place throughout 2025, this series wil...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
SEP 10, 2025
| 6:30 AM PDT
Join us for Innovations in Cancer Research Solutions , a 10-part virtual event showcasing the latest technologies advancing cancer research. From optimizing cell culture systems to studying...
C.E. CREDITS
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...
MAY 14, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to announce our 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 held on May 14th, 2025! The Precision Medicine: G...
APR 02, 2025
| 8:00 PM PDT
Oncomine World is back with brand NEW features Now in its sixth year, OncomineWorld meetings have united thousands of scientists and professionals from around the globe to advance genomic pr...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...